INSYS Therapeutics Reports Second Quarter 2018 Results

Focus remains on advancing pipeline across cannabinoid and spray platforms

PHOENIX, Aug. 08, 2018 (GLOBE NEWSWIRE) — INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids (CBD) and spray technology, today reported financial results for its second quarter ended June 30, 2018.

OVERALL HIGHLIGHTS

by

Leave a Reply